Home/ Supplements/ Vitamin C/ Corvite FE

Corvite FE

product on market Tablet or Pill Vertical Pharmaceuticals Safety: 96/100
96/100

This product looks safe

  • Ferronyl Carbonyl Iron: 125mg is 2.8× the Tolerable Upper Intake Level (45mg)
  • 80% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This profile combines iron, folate, and vitamin C, which have strong evidence for supporting red blood cell production and nutrient absorption. Calcium threonate provides supplemental mineral support. Overall evidence coverage for this specific formulation is limited, though the individual components are well-studied for nutritional deficiency.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Ferronyl Carbonyl Iron: 125mg is 2.8× the Tolerable Upper Intake Level (45mg)

Label

Product Label

Label for Corvite FE
Open Full PDF View on NIH DSLD →
Details

Label Data

1 {Tablet(s)}
Serving Size
Multi-Vitamin and Mineral (MVM)
Product Type
80%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Sumalate
25 mg
Exceeds UL by 2.8× (UL: 45 mg) 505 studies (A:17, B:273)
1 mg
2.5× RDA — within safe limits 226 studies (A:10, B:105)
Vitamin C
160 mg
Market median: 4002.0mg (1 products) 21 studies (A:0, B:2)
10 mg
7.7× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
15 mcg
6.2× RDA — above typical dose 139 studies (A:1, B:44)
1000 IU
1.7× RDA — within safe limits 608 studies (A:16, B:251)
25 mg
2.3× RDA — within safe limits 263 studies (A:6, B:134)
15 mg
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)

Other Ingredients

Black Iron Oxide Citric Acid Croscarmellose Sodium Di Calcium Phosphate Ethyl Cellulose FD&C Red #40 Lake fumed Silica Gum Arabic Hydroxypropyl Cellulose Hypromellose Magnesium Stearate Microcrystalline Cellulose Polyethylene Glycol Polysorbate 80 PVP K30 Talc Titanium Dioxide Tripotassium Citrate Vegetable oil
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

DOSAGE AND ADMINISTRATION Usual adult dose is 1 tablet daily, or as prescribed by a physician.

Warnings & Precautions

WARNINGS Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.

Folic Acid Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Pernicious anemia should be excluded before using this product since folic acid may mask the symptoms of pernicious anemia.

ADVERSE REACTIONS Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stools and abdominal pain. Adverse reactions with iron therapy are usually transient.

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

OVERDOSAGE The clinical course of acute iron overdosage can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanossi, lassitude, seizures, shock and coma.

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.

PRECAUTIONS General Do not exceed recommended dose. The type of anemia and the underlying cause or causes should be determined before starting therapy with CORVITE(R) FE. Since the anemia may be a result of a sytemic disturbance, such as recurrent blood loss, the underlying cause or causes should be corrected, if possible.

Pediatric Use Safety and effectiveness in pediatric patients have not been established.

Geriatric Use Clinical studies on this product have not been performed in subjects aged 65 and over to determine whether elderly subjects respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious.

KEEP THIS AND ALL DRUGS OUT OF REACH OF CHILDREN.

Additional Information

PRESCRIBING INFORMATION DESCRIPTION Red, oval bisected tablets embossed "VP042".

CLINICAL PHARMCOLOGY Iron is an essential component in the formation of hemoglobin. Adequate amounts of iron are necessary for effective erythropoiesis. Iron also serves as a cofactor of several essential enzymes, including cytochromes that are involved in electron transport. Folic acid is required for nucleoprotein synthesis and the maintenance of normal erythropoiesis. Folic acid is converted in the liver and plasma to its metabolically active form, tetrahydrofolic acid, by dihydrofolate reductase. Vitamin B12 is required for the maintenance of normal erythropoiesis, nucleoprotein and myelin synthesis, cell reproduction and normal growth. Intrinsic factor, a glycoprotein secreted by the gastric mucosa, is required for active absorption of vitamin B12 from the gastrointestinal tract.

CFELB021101

STORAGE Store at controlled room temperature 15(0)-30(0)C (59(0)-86(0)F) [See USP]. Protect from light, moisture and excessive heat. Dispense in a tight, light resistant container as defined in the USP using a child-resistant closure.

Rx Only.

Metadata

Product Details

DSLD Entry Date2013-11-25
Product TypeMulti-Vitamin and Mineral (MVM)
FormTablet or Pill
DSLD ID26580
Data Updated2026-04-11
Research

Research Evidence

371
Research Sources
54
Avg Quality
148
Meta Analysis
82
Systematic Review
71
Rct
62
Clinical Trial
2
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Other
1
Openfda Safety
A Vitamin C supplementation in pregnancy
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin C supplementation for the primary prevention of cardiovascular disease
Systematic Review The Cochrane database of systematic reviews 2017 PubMed DOI
A Vitamin C for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Vitamin C for preventing and treating pneumonia
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Vitamin E supplementation in pregnancy
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin C supplementation for prevention and treatment of pneumonia
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Vitamin C supplementation for prevention and treatment of pneumonia
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Nutritional interventions for preventing and treating pressure ulcers
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Does Vitamin C Supplementation Provide a Protective Effect in Periodontal Health? A Systematic Review and Meta-Analysis
Meta Analysis International journal of molecular sciences 2024 PubMed DOI
A Circulating vitamin C concentration and risk of cancers: a Mendelian randomization study
Meta Analysis BMC medicine 2021 PubMed DOI
View all evidence for Vitamin C →
Compare

Similar Products

View all Vitamin C products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.